Sunshine Act Meeting: Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 31780 [2017-14516]
Download as PDF
<![CDATA[
31780
Federal Register / Vol. 82, No. 130 / Monday, July 10, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
business loans are published in the
quarterly E.2 statistical release, Survey
of Terms of Business Lending, and
aggregate estimates for farm loans are
published in the E.15 statistical release,
Agricultural Finance Databook.
Legal authorization and
confidentiality: The Board’s Legal
Division has determined that these
surveys are authorized by section
11(a)(2) of the Federal Reserve Act (12
U.S.C. 248(a)(2)) which authorizes the
Board to require any depository
institution to make such reports of its
assets and liabilities as the Board may
determine to be necessary or desirable
to enable the Board to discharge its
responsibility to monitor and control
monetary and credit aggregates. The
reports are voluntary. Individual
responses reported on the FR 2028A, FR
2028B, FR 2028D, and FR 2028S are
regarded as confidential under the
Freedom of Information Act (5 U.S.C.
552(b)(4)).
Current actions: On April 21, 2017,
the Board published a notice in the
Federal Register (82 FR 18759)
requesting public comment for 60 days
on the extension, with revision, of the
FR 2028. The Federal Reserve proposed
to (1) discontinue the FR 2028A, (2)
create a new Small Business Lending
Survey (FR 2028D) that would provide
focused and enhanced information on
small business lending including rates,
terms, credit availability, and reasons
for their changes (in contrast to the
individual loan data collected on the FR
2028A, the FR 2028D would collect
quarterly average quantitative data on
terms of small business loans and
qualitative information on changes and
the reasons for changes in the terms of
lending), and (3) rename the STL the
Survey of Small Business and Farm
Lending (SSBFL) to more accurately
describe the data collection. No changes
were proposed to the FR 2028B and FR
2028S. The comment period for this
notice expired on June 20, 2017. The
Board did not receive any comments.
The revisions will be implemented as
proposed.
Board of Governors of the Federal Reserve
System, July 5, 2017.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2017–14401 Filed 7–7–17; 8:45 am]
BILLING CODE 6210–01–P
VerDate Sep<11>2014
16:08 Jul 07, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Sunshine Act Meeting: Advisory
Council for the Elimination of
Tuberculosis Meeting (ACET)
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2017–14516 Filed 7–6–17; 4:15 pm]
10:00 a.m.–3:30 p.m.,
EDT, August 22, 2017
PLACE: Web conference. Toll free
number 1–877–927–1433, Participant
Code: 12016435, To join the meeting:
https://adobeconnect.cdc.gov/
r5p8l2tytpq/.
STATUS: In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention announces the meeting of
the ACET. This meeting is open to the
public. The meeting room
accommodates 100 ports. Persons who
desire to make an oral statement, may
request it at the time of the public
comment period on August 22, 2017 at
3:20p.m. EDT. Public participation and
ability to comment will be limited to
space and time as it permits.
MATTERS TO BE CONSIDERED: This council
advises and makes recommendations to
the Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis (TB).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis. Agenda items include the
following topics: (1) Update on making
latent tuberculosis infection (LTBI)
reportable from the Council of State and
Territorial Epidemiologists (CSTE)
meeting; (2) Update data on LTBI testing
and treatment from Aggregate Reports
for Tuberculosis Program Evaluation
(ARPE); (3) Update on CDC’s efforts to
transition to whole-genome sequencing;
(4) Updates from Workgroups; and (5)
other tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Margie Scott-Cseh, CDC, 1600 Clifton
Road NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
TIME AND DATE:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Sunshine Act Meeting: Advisory Board
on Radiation and Worker Health
(ABRWH or Advisory Board), National
Institute for Occupational Safety and
Health (NIOSH)
TIME/S/ AND DATE/S/:
8:15 a.m.–5:30 p.m., Mountain Time,
August 23, 2017
8:15 a.m.–4:30 p.m., Mountain Time,
August 24, 2017
PUBLIC COMMENT TIMES AND DATES: 5:30
p.m.–6:30 p.m., Mountain Time, August
23, 2017.
PLACE: Courtyard Marriott, 3347
Cerrillos Road, Santa Fe, New Mexico
87507; Phone: (505) 473–2800 Fax: (505)
473–5128.
STATUS: In accordance with section
10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the
aforementioned committee. This
meeting is Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people. Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 with a pass
code of 9933701. Skype Meeting
Connection: https://webconf.cdc.gov/
zab6/yzdq02pl?sl=1
MATTERS TO BE CONSIDERED: The
Advisory Board was established under
the Energy Employees Occupational
Illness Compensation Program Act of
2000 to advise the President on a variety
of policy and technical functions
required to implement and effectively
manage the new compensation program.
Key functions of the Advisory Board
include providing advice on the
development of probability of causation
guidelines which have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule, advice on methods of dose
reconstruction which have also been
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Page 31780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14516]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Sunshine Act Meeting: Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Time and Date: 10:00 a.m.-3:30 p.m., EDT, August 22, 2017
Place: Web conference. Toll free number 1-877-927-1433, Participant
Code: 12016435, To join the meeting: https://adobeconnect.cdc.gov/r5p8l2tytpq/.
Status: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention announces the meeting of the ACET. This meeting is open to
the public. The meeting room accommodates 100 ports. Persons who desire
to make an oral statement, may request it at the time of the public
comment period on August 22, 2017 at 3:20p.m. EDT. Public participation
and ability to comment will be limited to space and time as it permits.
Matters to be Considered: This council advises and makes
recommendations to the Secretary of Health and Human Services, the
Assistant Secretary for Health, and the Director, CDC, regarding the
elimination of tuberculosis (TB). Specifically, the Council makes
recommendations regarding policies, strategies, objectives, and
priorities; addresses the development and application of new
technologies; and reviews the extent to which progress has been made
toward eliminating tuberculosis. Agenda items include the following
topics: (1) Update on making latent tuberculosis infection (LTBI)
reportable from the Council of State and Territorial Epidemiologists
(CSTE) meeting; (2) Update data on LTBI testing and treatment from
Aggregate Reports for Tuberculosis Program Evaluation (ARPE); (3)
Update on CDC's efforts to transition to whole-genome sequencing; (4)
Updates from Workgroups; and (5) other tuberculosis-related issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, CDC, 1600
Clifton Road NE., M/S E-07, Atlanta, Georgia 30333, telephone (404)
639-8317; Email: zkr7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2017-14516 Filed 7-6-17; 4:15 pm]
BILLING CODE 4163-18-P
